Success of TrumpRx, other discount drug websites, depends on consumer “homework”

TrumpRx is a new government direct-to-consumer drug portal for more than 40 generic drugs. The website has been live for less than a month, officially launching on Feb. 5, 2026, but has already received some criticism, with critics pointing out that the cash-only discounts are already available from some pharmaceutical companies. For example, Novo already sells injectable Wegovy at the same starting price as TrumpRx.

In a recent interview with Managed Healthcare Executive, Joseph Kleiman, president of Buzz Health, said that even though it’s new, there is one change he would make.

“I can't really say I’d change anything at this point, except for maybe adding more drugs,” Kleiman said.

Generic drugs in the United States account for approximately 90% of all drugs dispensed but only account for approximately 20% of total prescription drug spending.

Kleiman said this is where the consumer can take initiative.

“If you're prescribed a brand medication, check to see if there's a generic alternative, then check to see the available discounts out there, whether it's TrumpRx or any of the other discount offerings out there. Do your homework.”

Buzz Health is a healthcare technology company offering customizable prescription savings solutions that integrate with health systems to promote price transparency and a more cost-effective prescription ecosystem, their website states.